What are the current research directions involving CDKN2A?
Research on CDKN2A continues to uncover new insights into its role in cancer. Studies are focusing on understanding the molecular mechanisms by which CDKN2A mutations contribute to tumorigenesis, identifying potential therapeutic targets, and developing novel treatments that can restore the function of its encoded proteins. Additionally, researchers are exploring the use of CDKN2A status as a biomarker for predicting treatment response and patient outcomes.
